Association Between Sleep Disorders and Subsequent Heart Failure

Overview

Journal Int J Cardiol Heart Vasc

Date 2025 Feb 10

PMID 39925774

Authors

Jamschid Sedighi

Mark Luedde

Julia Gaensbacher-Kunzendorf

Hans-Joerg Hippe

Pascal Bauer

Birgit Assmus

Samuel Sossalla

Karel Kostev

Affiliations

Soon will be listed here.

Abstract

Background: Sleep disorders are prevalent conditions that may influence the progression of various heart diseases. However, the relationship between sleep disorders and the onset of heart failure (HF) remains unclear.

Objective: The purpose of this study was to investigate whether sleep disorders are associated with an increased risk of developing HF.

Methods: We conducted a retrospective cohort study using data from 1,293 general practices across Germany sourced from the IQVIA Disease Analyzer database. The study included patients with an initial diagnosis of HF (ICD-10 code: I50) between January 2010 and December 2022 (index data) These patients were matched with control subjects without HF based on age, sex, and pre-existing conditions. The primary outcome was the association between prior sleep disorder diagnoses and the subsequent development of HF. Data were available for 9,345,246 individuals, of which 406,265 had a history of HF.

Results: The study analyzed data from 123,516 patients with HF and an equal number of matched controls. The mean age of participants was 73.3-73.4 (SD 12.4) years, with 53.2% being women. Sleep disorders diagnosed prior to the onset of HF were significantly associated with an increased risk of developing HF. This association was consistent across different types of sleep disorders overall (OR: 1.22; 95%CI: 1.19-1.24) as well as insomnia (OR: 1.26; 95%CI: 1.21-1.31), sleep apnea (OR: 1.20; 95%CI: 1.15-1.25), and unspecified sleep disorders (OR: 1.21; 95%CI: 1.18-1.25).

Conclusion: In this large cohort of outpatients, a prior diagnosis of sleep disorders was linked to a higher incidence of HF. These findings suggest that sleep disorders may serve as a risk factor for the development of HF, highlighting the need for early identification and management of sleep disturbances in at-risk populations. Addressing these disorders in clinical practice could represent a pivotal step towards better cardiovascular health and patient care.

References

Javaheri S, Javaheri S, Somers V, Gozal D, Mokhlesi B, Mehra R . Interactions of Obstructive Sleep Apnea With the Pathophysiology of Cardiovascular Disease, Part 1: JACC State-of-the-Art Review. J Am Coll Cardiol. 2024; 84(13):1208-1223. PMC: 11666391. DOI: 10.1016/j.jacc.2024.02.059. View

Parati G, Lombardi C, Castagna F, Mattaliano P, Filardi P, Agostoni P . Heart failure and sleep disorders. Nat Rev Cardiol. 2016; 13(7):389-403. DOI: 10.1038/nrcardio.2016.71. View

Baessler A, Nadeem R, Harvey M, Madbouly E, Younus A, Sajid H . Treatment for sleep apnea by continuous positive airway pressure improves levels of inflammatory markers - a meta-analysis. J Inflamm (Lond). 2013; 10:13. PMC: 3637233. DOI: 10.1186/1476-9255-10-13. View

Sofi F, Cesari F, Casini A, Macchi C, Abbate R, Gensini G . Insomnia and risk of cardiovascular disease: a meta-analysis. Eur J Prev Cardiol. 2012; 21(1):57-64. DOI: 10.1177/2047487312460020. View

Picchioni D, Reith R, Nadel J, Smith C . Sleep, plasticity and the pathophysiology of neurodevelopmental disorders: the potential roles of protein synthesis and other cellular processes. Brain Sci. 2014; 4(1):150-201. PMC: 4020186. DOI: 10.3390/brainsci4010150. View

Greenlund I, Carter J . Sympathetic neural responses to sleep disorders and insufficiencies. Am J Physiol Heart Circ Physiol. 2022; 322(3):H337-H349. PMC: 8836729. DOI: 10.1152/ajpheart.00590.2021. View

Piccirillo F, Crispino S, Buzzelli L, Segreti A, Antonelli Incalzi R, Grigioni F . A State-of-the-Art Review on Sleep Apnea Syndrome and Heart Failure. Am J Cardiol. 2023; 195:57-69. DOI: 10.1016/j.amjcard.2023.02.020. View

Rathmann W, Bongaerts B, Carius H, Kruppert S, Kostev K . Basic characteristics and representativeness of the German Disease Analyzer database . Int J Clin Pharmacol Ther. 2018; 56(10):459-466. DOI: 10.5414/CP203320 . View

Spiesshoefer J, Linz D, Skobel E, Arzt M, Stadler S, Schoebel C . Sleep - the yet underappreciated player in cardiovascular diseases: A clinical review from the German Cardiac Society Working Group on Sleep Disordered Breathing. Eur J Prev Cardiol. 2021; 28(2):189-200. DOI: 10.1177/2047487319879526. View

10.

Redline S, Azarbarzin A, Peker Y . Obstructive sleep apnoea heterogeneity and cardiovascular disease. Nat Rev Cardiol. 2023; 20(8):560-573. DOI: 10.1038/s41569-023-00846-6. View

11.

Gottlieb D, Yenokyan G, Newman A, OConnor G, Punjabi N, Quan S . Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation. 2010; 122(4):352-60. PMC: 3117288. DOI: 10.1161/CIRCULATIONAHA.109.901801. View

12.

McDonagh T, Metra M, Adamo M, Gardner R, Baumbach A, Bohm M . 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021; 42(36):3599-3726. DOI: 10.1093/eurheartj/ehab368. View

13.

Grandner M, Mullington J, Hashmi S, Redeker N, Watson N, Morgenthaler T . Sleep Duration and Hypertension: Analysis of > 700,000 Adults by Age and Sex. J Clin Sleep Med. 2018; 14(6):1031-1039. PMC: 5991947. DOI: 10.5664/jcsm.7176. View

14.

Fink A, Bronas U, Calik M . Autonomic regulation during sleep and wakefulness: a review with implications for defining the pathophysiology of neurological disorders. Clin Auton Res. 2018; 28(6):509-518. PMC: 6542468. DOI: 10.1007/s10286-018-0560-9. View

15.

Scala O, Paolillo S, Formisano R, Pellegrino T, Rengo G, Gargiulo P . Sleep-disordered breathing, impaired cardiac adrenergic innervation and prognosis in heart failure. Heart. 2016; 102(22):1813-1819. DOI: 10.1136/heartjnl-2015-309215. View